5 August 2024 - PHARMAC is looking to fund a medicine for bowel cancer that would help people live longer.
Public consultation has opened on PHARMAC’s proposal to fund cetuximab (Erbitux) for a type of bowel cancer where the cancer is located on the left side of the bowel and has spread to other parts of the body.